 GERMANTOWN, Md., Jan. 5, 2021 PRNewswire -- Precigen, Inc. Nasdaq: PGEN, a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the lives of patients, today announced that the US Food and Drug Administration FDA has cleared the... 